Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1630 of 6351
-
Could this pill clear long COVID brain fog? new trial begins
Symptom relief OngoingLong COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things …
Phase 2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Tailored blood thinners could save limbs in PAD patients
Disease control Recruiting nowThe goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery disease (PAD) who have undergone a procedure to restore blood flow to their legs. The main questions it ai…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat lung cancer: experimental drug combo enters trial
Disease control Recruiting nowThe purpose of this study is to determine the overall safety and tolerability of JBI-802 as single agent and in combination with Pembrolizumab.
Phase 2 • Sponsor: The Christ Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for Post-Surgery sugar crashes: avexitide trial underway
Disease control OngoingAVX-001 (LUCIDITY) is a Phase 3 study to evaluate avexitide compared to placebo in participants with post bariatric hypoglycemia (PBH) related to Roux-en-Y gastric bypass (RYGB). The study will assess avexitide compared to placebo for safety and efficacy, measured by reduction of…
Phase 3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug BL-M14D1 targets tough cancers in early human trial
Disease control Recruiting nowThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Phase 1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Ketamine tested as new hope for long COVID brain fog and exhaustion
Symptom relief CompletedPlain Language Summary: This study is a clinical trial to see if ketamine can help treat symptoms of Long COVID, especially fatigue and problems with thinking clearly (often called "brain fog"). Long COVID is a condition that affects people even after they have recovered from CO…
Phase 2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is a multicentre, open phase II clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in combination with antitumor drugs in subjects with advanced malignant tumour. To evaluate the safety, tolerability and efficacy of HRS-7058 in combina…
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Common painkiller ibuprofen tested as treatment for heart inflammation
Disease control Recruiting nowProspective, randomized, multicenter, open-label clinical trial to evaluate the safety and efficacy of a 3-week ibuprofen tapering regimen compared to conventional analgesic treatment (acetaminophen) in patients with acute myocarditis and left ventricular ejection fraction ≥50%. …
Phase 3 • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Balloons may beat stents for tough heart blockages
Disease control Recruiting nowThe aim of this study is to evaluate the long-term efficacy and safety of drug-coated balloon (DCB) strategies, including DCB alone or hybrid strategies of DCB and drug-eluting stent (DES), compared to DES-only in patients with chronic total occlusion (CTO) after successful recan…
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New app and coaching aim to help minorities manage chronic pain without pills
Symptom relief Recruiting nowINSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot …
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New eczema cream shows promise in early trial
Symptom relief CompletedA multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Phase 2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New radioactive antibody could make sickle cell transplants safer
Disease control Recruiting nowThe purpose of this study is to find the smallest amount of the 131 I-apamistamab needed for preparing patients with severe sickle cell disease (SCD) for a bone marrow transplant. This is the first time 131 I-apamistamab is being used for advanced Sickle Cell Disease (SCD) in the…
Phase 1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a website ease the emotional toll of stem cell transplants?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Pat…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Sharper blood test could uncover hidden cause of high blood pressure
Diagnosis Recruiting nowPrimary aldosteronism (PA) is the most common cause of secondary hypertension. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is more accurate than the traditional radioimmunoassay method in measuring aldosterone. This study aims to establish a more precise diagnostic …
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Vibrating tendons may steady shaky legs — a trial puts it to the test
Symptom relief Recruiting nowCharcot-Marie-Tooth (CMT) disease is caused by a genetic abnormality involving the PMP22 gene, resulting in demyelination of the peripheral nerves. Demyelination leads to sensorimotor impairment and causes progressive muscle weakness and tendon contractures, initially affecting t…
Sponsor: UGECAM PACA et Corse • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a One-Month diet shift diabetes biomarkers?
Knowledge-focused CompletedThe goal of this clinical trial is to explore the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in diabetes in healthy adults. The primary objective is to…
Sponsor: Indonesia University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New hope for lymphoma patients: drug combo trial aims to shrink tumors
Disease control Recruiting nowThe purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in the United States, including under-represented racial and ethnic populations, that have relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for hard-to-treat leukemia? early trial tests eganelisib alone and with chemo.
Disease control Recruiting nowThis is a Phase 1b open-label, multicenter, dose-escalation and dose-optimization study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor efficacy of eganelisib as monotherapy and in combination with cytarabine in patients…
Phase 1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Weekly shot could replace daily needles for short kids
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase III clinical trial to evaluate the efficacy and safety of Inpegsomatropin injection,once a week,compared with recombinant human growth hormone (rhGH) in children with idiopathic short stature (ISS). It plans t…
Phase 3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a gentle forehead zap during sleep ease ADHD in kids with fetal alcohol exposure?
Symptom relief Recruiting nowThis is an open-label trial of trigeminal nerve stimulation (TNS) for children aged 8-12 years with attention deficit hyperactivity disorder (ADHD) putatively due to prenatal alcohol exposure (PAE). TNS has been successful in treating pediatric ADHD generally and it is US Food an…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC